IL9 and acute myeloid leukemia: Nonetheless, analysis of TCGA datasets in AML provide clinical evidence that an IL-9-rich environment in combination with Vγ9Vδ2 TILs was linked with the best prognosis, suggesting that this cytokine contributes importantly in vivo to γδ[T2] cell biology.